Pfizer will submit its lung cancer candidate crizotinib to the FDA for US approval in the first half of next …
Ofichem acquires US drug substance CDMO Kinentia
Jager-van Dijk is new Arletta Pharma Solutions CEOÂ
Tridem begins phase Ib trial of Parkinson’s disease vaccine

